# Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/adjuvant-capecitabine-with-docetaxel-and-cyclophosphamide-plus-epirubicin-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Junjie Li,Ke‐Da Yu,Da Pang,Changqin Wang,Jun Jiang,Suisheng Yang,Yunjiang Liu,Peifen Fu,Yuan Sheng,Guo‐Jun Zhang,Yali Cao,Qi He,Shude Cui,Xi-Jing Wang,Guosheng Ren,Xinzheng Li,Shiyou Yu,Pengxi Liu,Xiang Qu,Jinhai Tang,Ouchen Wang,Zhimin Fan,Guoqin Jiang,Jin Zhang,Jiandong Wang,Hongwei Zhang,Shui Wang,Jianguo Zhang,Feng Jin,Nanyan Rao,Binlin Ma,Pingqing He,Binghe Xu,Zhigang Zhuang,Jianfeng Wang,Qiang Sun,Xiaofeng Guo,Miao Mo,Zhimin Shao,on behalf of the CBCSG010 Study Group |
| Citations | 106 |
| DOI | 10.1200/jco.19.02474 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1200/jco.19.02474 |
| OpenAlex ID | https://openalex.org/W3015248490 |
| PMID | 32275467 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Miao Mo](https://scholariq.org/researchers/miao-mo/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Paper topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.